Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
EXPO > SEC Filings for EXPO > Form 8-K on 2-Jun-2009All Recent SEC Filings

Show all filings for EXPONENT INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for EXPONENT INC


2-Jun-2009

Change in Directors or Principal Officers, Financial Statements and Exhibits


Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On May 28, 2009, Exponent's Board of Directors appointed Dr. Paul R. Johnston as its Chief Executive Officer and President. Dr. Johnston, age 55, joined Exponent in 1981 and has assumed increasingly responsible positions over time, most recently being named Chief Operating Officer in 2003 and President in 2007. In these roles, Dr. Johnston was initially responsible for Exponent's Health and Environmental businesses before assuming management of all of Exponent's consulting groups. He has also managed Exponent's network of offices. He is a Registered Professional Civil Engineer in the State of California. Upon his appointment as Chief Executive Officer and President, Dr. Johnston's base salary was set at $525,000. Dr. Johnston's target bonus level is equal to his blended base salary for the year and his performance objectives will be substantially the same as those disclosed for the Company's Chief Executive Officer in Exponent's 2009 Proxy Statement.

Upon Dr. Johnston's appointment, Michael R. Gaulke was appointed Executive Chairman and will continue in this role for twelve months. Mr. Gaulke, age 63, previously served as Chief Executive Officer, a position from which he stepped down upon Dr. Johnston's appointment as Chief Executive Officer and President. Mr. Gaulke joined Exponent in 1992, as Executive Vice President and Chief Financial Officer. He was named President in March 1993, and he was appointed as a member of the Board of Directors of Exponent in January 1994. He assumed the role of Chief Executive Officer in June 1996, and was appointed Chairman of the Board of Directors in May 2007. Prior to 1992, he held senior executive positions at Raynet Corporation and Spectra Physics, and was a consultant with McKinsey & Company. Mr. Gaulke is a Member of the Board of Cymer, Inc. and the Board of Trustees of the Palo Alto Medical Foundation. Upon his appointment as Executive Chairman, Mr. Gaulke's base salary was set at $300,000 and he was granted a restricted stock unit award with a value of $80,000 that vests ratably over one year. Mr. Gaulke's target bonus level is equal to his blended base salary for the year and his performance objectives will be substantially the same as those disclosed for the Company's Chief Executive Officer in Exponent's 2009 Proxy Statement.



Item 9.01. Financial Statements and Exhibits

The Press Release included as Exhibit 99.1 of this Current Report on Form 8-K shall be considered "furnished" pursuant to this Current Report on Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, nor shall it be deemed incorporated by reference into any of the Registrant's reports or filings with the Securities and Exchange Commission, whether made before or after the date hereof, except as expressly set forth by specific reference in such a filing.

    Exhibit
    Number    Description

     99.1     Press release announcing executive transition dated May 28, 2009


  Add EXPO to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for EXPO - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.